March 24, 2026. 9 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Scientists Identify Protein That Slows Key Effects of Aging – SciTechDaily
This article discusses aging-related immune inflammation (inflammaging), which may interest cannabis clinicians given cannabis’s documented immunomodulatory properties and potential applications in age-related inflammatory conditions.
Read more →Great Lakes, Ohio Breweries Urge Legislative Override Vote on THC Beverage Bill | BevNET.com
Ohio breweries are advocating for legislative action to preserve hemp-derived THC beverage availability, potentially affecting product regulation and consumer access patterns clinicians should monitor.
Read more →Three marijuana bills head to the Tennessee Legislature this week – The Lynchburg Times
Article covers how municipalities in Michigan, New Mexico, and Oregon allocate marijuana tax revenue, relevant to clinicians tracking cannabis policy’s fiscal structures and healthcare funding implications.
Read more →Over $140 million in marijuana taxes sent back to U.P. cities, counties, and tribes | News
Article reports marijuana tax revenue distributions ($140M+) to Michigan Upper Peninsula municipalities and tribes, which may interest clinicians tracking cannabis regulatory frameworks and local implementation outcomes.
Read more →Cheech and Chong’s Global Holding Company Partners with Breakthru Beverage Group to …
Summary This article covers a distribution partnership for THC beverages, which may interest clinicians tracking cannabis product commercialization and beverage formulation trends in the market.
Read more →US (CA): Solful to open fourth dispensary in Petaluma – MMJDaily
This brief business announcement covers a California dispensary expansion and mentions cannabis research collaboration between Yale and McGill universities, which may interest clinicians tracking institutional research developments.
Read more →Blacksburg prepares for legal cannabis market – YouTube
Summary This article covers Blacksburg’s preparations for a legal cannabis market, which may interest clinicians monitoring regulatory developments and market implementation in their region.
Read more →Army raises enlistment age to 42, removes waiver for marijuana possession – Reddit
The U.S. Army formalized its policy by removing marijuana possession waivers and raising enlistment age to 42, reflecting evolving institutional attitudes toward cannabis use.
Read more →Anti-Aging Protein Research Takes a Step Forward with Cell Cloning – PR Newswire
Article Summary This article reports on anti-aging protein research using cell cloning techniques, which may interest cannabis clinicians studying cannabinoid effects on cellular aging and senescence mechanisms.
Read more →Digest-Level Clinical Commentary
Clinical Reflection These items collectively signal three converging trends that will reshape cannabis medicine practice: the scientific validation of cannabinoids’ immunomodulatory potential in addressing age-related inflammation, the rapid commercialization and mainstream distribution infrastructure that will increase patient access and questions about quality and dosing, and importantly, the normalization of cannabis use evidenced by military policy shifts that suggests our patient populations will increasingly include individuals with prior or concurrent cannabis exposure. As cannabis medicine practitioners, we must prepare to engage with patients who arrive with commercial product experience rather than medical guidance, while simultaneously staying current with emerging basic science on cannabinoid mechanisms that may inform therapeutic applications in conditions like inflammaging.
These items reflect two distinct but parallel developments in cannabis policy and science. On the regulatory side, we see continued expansion of legal cannabis markets with increased tax revenue allocation and beverage product distribution, alongside shifting military and institutional policies that reduce barriers to cannabis-related convictions. On the research side, emerging studies on cannabinoid effects and aging mechanisms suggest potential clinical applications, though the evidence base remains preliminary and separate from the commercial marketplace expansion documented in these reports.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it: